Bank of New York Mellon
BDSX icon

Bank of New York Mellon’s Biodesix BDSX Stock Holding History

Bank of New York Mellon’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-700
Closed -$3.95K – 4179
2025
Q2 		$3.95K Hold
700
– – ﹤0.01% 4135
2025
Q1 		$8.76K Hold
700
– – ﹤0.01% 4104
2024
Q4 		$21.4K Hold
700
– – ﹤0.01% 4103
2024
Q3 		$24.9K Hold
700
– – ﹤0.01% 4068
2024
Q2 		$21.4K Buy
+700
New +$20K ﹤0.01% 4079
2022
Q2 		– Sell
-1,485
Closed -$50K – 4593
2022
Q1 		$50K Buy
1,485
+7
+0.5% +$457 ﹤0.01% 4521
2021
Q4 		$156K Buy
1,478
+32
+2% +$4.18K ﹤0.01% 4339
2021
Q3 		$237K Sell
1,446
-57
-4% -$10.8K ﹤0.01% 4133
2021
Q2 		$397K Buy
1,503
+813
+118% +$256K ﹤0.01% 3874
2021
Q1 		$280K Buy
690
+134
+24% +$59.9K ﹤0.01% 3935
2020
Q4 		$224K Buy
+556
New +$173K ﹤0.01% 3941

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon's BDSX Position: Q3 2025 in Review

Bank of New York Mellon sold out of Biodesix (BDSX) in Q3 2025, closing a stake of 700 shares — an estimated $3.95K sold.

Bank of New York Mellon first reported a position in BDSX in Q4 2020 and held it in 11 quarters. The position peaked at $397K in Q2 2021. 26 funds tracked by Wall St. Rank hold BDSX as of Q3 2025.

  • Bank of New York Mellon reported no remaining Biodesix position as of Q3 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 700 Biodesix shares in Q3 2025, an estimated $3.95K.
  • Bank of New York Mellon first reported a position in Biodesix in Q4 2020 and held it in 11 quarters.
  • Bank of New York Mellon's Biodesix position peaked at $397K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q3 2025.

Based on Bank of New York Mellon's 13F filing for Q3 2025, filed 3 Nov 2025.